ZeroStack faces existential financial strain as its 0G token treasury value plummets by 91%, threatening the company’s ability to continue operations. The decline in treasury reserves raises serious concerns about liquidity and sustainability. No alternative funding or strategic pivots are mentioned in the report.
ZeroStack Corp. secures up to **$14.7 million** in pharmaceutical distribution purchase orders from two unnamed companies, to be fulfilled via its German subsidiary, **Phatebo GmbH**. The orders target inventory sales in Germany, expanding the AI-focused asset management firm’s pharmaceutical supply chain operations. ZeroStack, listed on NASDAQ as **ZSTK**, leverages its wholly owned subsidiary to execute the deals.
ZeroStack announces a $107 million cryptocurrency financing and plans to redomicile to Texas. Investors contributed 142.2 million 0G tokens to Texas Blocker Corp.; the financing’s closing and the redomicile remain subject to approvals and other conditions.
Flora Growth says it will change its name to ZeroStack Corp. and trade on Nasdaq under ticker ZSTK. The company says the change advances its strategy as an AI-focused asset-management company.